BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8437597)

  • 1. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors.
    Shivdasani RA; Haluska FG; Dock NL; Dover JS; Kineke EJ; Anderson KC
    N Engl J Med; 1993 Mar; 328(11):766-70. PubMed ID: 8437597
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.
    Thaler M; Shamiss A; Orgad S; Huszar M; Nussinovitch N; Meisel S; Gazit E; Lavee J; Smolinsky A
    N Engl J Med; 1989 Jul; 321(1):25-8. PubMed ID: 2786605
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells.
    Suzuki K; Akiyama H; Takamoto S; Maruyama Y; Sakamaki H; Akagi K; Maeda Y; Takenaka M; Onozawa Y
    Transfusion; 1992 May; 32(4):358-60. PubMed ID: 1585443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transfusion related graft versus host disease. Indications for irradiated blood components].
    Muñiz-Díaz E; Martínez Valverde C; Sierra J; Madoz P
    Sangre (Barc); 1999 Dec; 44(6):483-8. PubMed ID: 10822764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
    García Gala JM; Ramírez Páyer A; Rayón C; Rodríguez Vicente P; Rosón C; Blanco C
    Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-associated graft-versus-host disease, monoclonal gammopathy and PCR.
    Blundell EL; Pamphilon DH; Anderson NA; Slade RR; Burton PA; Martin A; Ray T; Bradley BA; Lawler M; Humphries P
    Br J Haematol; 1992 Nov; 82(3):622-3. PubMed ID: 1486045
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion-associated graft-versus-host disease.
    Anderson KC; Weinstein HJ
    N Engl J Med; 1990 Aug; 323(5):315-21. PubMed ID: 2248640
    [No Abstract]   [Full Text] [Related]  

  • 9. [HLA and transfusion].
    Wittmann G; Zimmermann R; Eckstein R
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):207-12. PubMed ID: 7919910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor.
    Gorman TE; Julius CJ; Barth RF; Ng A; Kennedy MS; Prior TW; Allen J; Lasky LC
    Am J Clin Pathol; 2000 May; 113(5):732-7. PubMed ID: 10800407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual immunological risks associated with red blood cell transfusion.
    Rouger P; Le Pennec PY
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):217-9. PubMed ID: 8337131
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of MLC for BMT with serological HLA-identical related and unrelated donors.
    Bonfichi M; Bernasconi P; Brera C; Boni M; Caldera C; Campagnoli C; Alessandrino EP; Bernasconi C
    Bone Marrow Transplant; 1993; 11 Suppl 1():28-30. PubMed ID: 8448540
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-homozygous donors and transfusion-associated graft-versus-host disease.
    N Engl J Med; 1990 Apr; 322(14):1004-7. PubMed ID: 2314438
    [No Abstract]   [Full Text] [Related]  

  • 14. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
    Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
    Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post-transfusion graft-versus-host disease].
    Takahashi K
    Rinsho Ketsueki; 1992 May; 33(5):582-6. PubMed ID: 1630009
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of transfusion-associated graft-versus-host disease.
    Yasuda H; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):69-75. PubMed ID: 7927137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Johnsen HE
    N Engl J Med; 1993 May; 328(20):1497-8. PubMed ID: 8479479
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
    Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
    Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
    Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
    Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.